Related references
Note: Only part of the references are listed.Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series
Manon Martins et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2022)
Advances in the management of TTP
M. Subhan et al.
BLOOD REVIEWS (2022)
Clinical Outcome and Underlying Genetic Cause of Functional Terminal Complement Pathway Deficiencies in a Multicenter UK Cohort
Annalie Shears et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2022)
Ultrarapid Nanopore Genome Sequencing in a Critical Care Setting
John E. Gorzynski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Adult-onset CblC deficiency: a challenging diagnosis involving different adult clinical specialists
Silvia Kalantari et al.
ORPHANET JOURNAL OF RARE DISEASES (2022)
Proteinuria Increases the PLASMIC and French Scores Performance to Predict Thrombotic Thrombocytopenic Purpura in Patients With Thrombotic Microangiopathy Syndrome
Nicolas Fage et al.
KIDNEY INTERNATIONAL REPORTS (2022)
Pregnancy in Women with Atypical Hemolytic Uremic Syndrome
Eric Rondeau et al.
NEPHRON (2022)
Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study
Fadi Fakhouri et al.
BLOOD (2021)
IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome
Massimo Cugno et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Thrombotic Microangiopathy, an Unusual Form of Monoclonal Gammopathy of Renal Significance: Report of 3 Cases and Literature Review
Edward J. Filippone et al.
FRONTIERS IN IMMUNOLOGY (2021)
Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics
Fadi Fakhouri et al.
NATURE REVIEWS NEPHROLOGY (2021)
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
Peter Hillmen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
Antonio M. Risitano et al.
LANCET HAEMATOLOGY (2021)
COVID-19 as a potential trigger of complement-mediated atypical HUS
Carine El Sissy et al.
BLOOD (2021)
Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals
Angela Liu et al.
TRANSFUSION (2021)
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment
Eric Rondeau et al.
KIDNEY INTERNATIONAL (2020)
Cobalamin c deficiency associated with antifactor h antibody-associated hemolytic uremic syndrome in a young adult
C. Philipponnet et al.
BMC NEPHROLOGY (2020)
Eculizumab impairs Neisseria meningitidis serogroup B killing in whole blood despite 4CMenB vaccination of PNH patients
Jeroen D. Langereis et al.
BLOOD ADVANCES (2020)
Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group
Fadi Fakhouri et al.
BLOOD (2020)
A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP
Paul Coppo et al.
BLOOD (2020)
Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort
Sebastien Rubin et al.
JOURNAL OF HYPERTENSION (2019)
Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis
Gerard Socie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Complement Gene Variants and Shiga Toxin-Producing Escherichia coli-Associated Hemolytic Uremic Syndrome Retrospective Genetic and Clinical Study
Veronique Fremeaux-Bacchi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome
Khalil El Karoui et al.
HAEMATOLOGICA (2019)
Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors
Alice Le Clech et al.
KIDNEY INTERNATIONAL (2019)
Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation
Yoshiyasu Ueda et al.
KIDNEY INTERNATIONAL (2019)
Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study
Jan Menne et al.
BMC NEPHROLOGY (2019)
Monoclonal gammopathy-associated thrombotic microangiopathy
Jennifer C. Yui et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017)
Shamez N. Ladhani et al.
BMC INFECTIOUS DISEASES (2019)
Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome
Teresa Cavero et al.
KIDNEY INTERNATIONAL (2019)
Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT
Antonio M. Risitano et al.
FRONTIERS IN IMMUNOLOGY (2019)
Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome
Julien Zuber et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Complement Activation and Thrombotic Microangiopathies
Marta Palomo et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Disseminated Gonococcal Infections in Patients Receiving Eculizumab: A Case Series
Page E. Crew et al.
CLINICAL INFECTIOUS DISEASES (2019)
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
M. Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
ESC Council on hypertension position document on themanagement of hypertensive emergencies
Bert-Jan H. van den Born et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2019)
Genetic testing of complement and coagulation pathways in patients with severe hypertension and renal microangiopathy
Christopher P. Larsen et al.
MODERN PATHOLOGY (2018)
Safety and effectiveness of restrictive eculizumab treatment in atypical haemolytic uremic syndrome
Kioa L. Wijnsma et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome
Ana Huerta et al.
KIDNEY INTERNATIONAL (2018)
Complete functional characterization of disease-associated genetic variants in the complement factor H gene
Hector Martin Merinero et al.
KIDNEY INTERNATIONAL (2018)
Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome
Franz Schaefer et al.
KIDNEY INTERNATIONAL (2018)
A rare case of septic shock due to Neisseria meningitidis serogroup B infection despite prior vaccination in a young adult with paroxysmal nocturnal haemoglobinuria receiving eculizumab
Dominik Reher et al.
VACCINE (2018)
Meningococcal B Vaccine Immunogenicity in Children With Defects in Complement and Splenic Function
Federico Martinon-Torres et al.
PEDIATRICS (2018)
Pregnancy-induced atypical haemolytic uremic syndrome: A new era with eculizumab
Renuka Shanmugalingam et al.
OBSTETRIC MEDICINE (2018)
Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation
Fadi Fakhouri et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry
Alena Shantsila et al.
JOURNAL OF HYPERTENSION (2017)
Strains Responsible for Invasive Meningococcal Disease in Patients With Terminal Complement Pathway Deficiencies
Jeremie Rosain et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Thrombotic microangiopathy associated with monoclonal gammopathy
Aishwarya Ravindran et al.
KIDNEY INTERNATIONAL (2017)
Life-threatening pregnancy-associated atypical haemolytic uraemic syndrome and its response to eculizumab
Ryan Gately et al.
NEPHROLOGY (2017)
Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term Eculizumab
Sydel R. Parikh et al.
PEDIATRICS (2017)
Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study
Pavan K. Bendapudi et al.
LANCET HAEMATOLOGY (2017)
Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series
Caroline Duineveld et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2017)
Hemolytic Uremic Syndrome in Pregnancy and Postpartum
Alexandra Bruel et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Eculizumab cessation in atypical hemolytic uremic syndrome
Samuel A. Merrill et al.
BLOOD (2017)
A national specialized service in England for atypical haemolytic uraemic syndrome-the first year's experience
N. S. Sheerin et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2016)
Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial
Fadi Fakhouri et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab
Aude Servais et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome
Antonio F. Saad et al.
AJP REPORTS (2016)
Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody
Claire Rigothier et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Discontinuation of Eculizumab Treatment in Atypical Hemolytic Uremic Syndrome: An Update
Gianluigi Ardissino et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Discontinuation of Eculizumab Maintenance Treatment for Atypical Hemolytic Uremic Syndrome
Jack F. M. Wetzels et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Modified Ham test for atypical hemolytic uremic syndrome
Eleni Gavriilaki et al.
BLOOD (2015)
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury
Sonata Jodele et al.
BLOOD REVIEWS (2015)
Spectrum and Management of Complement Immunodeficiencies (Excluding Hereditary Angioedema) Across Europe
A. J. Turley et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2015)
Evaluation of Enzyme Immunoassays and Real-Time PCR for Detecting Shiga Toxin-Producing Escherichia coli in Southern Alberta, Canada
Linda Chui et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies
Christoph Licht et al.
KIDNEY INTERNATIONAL (2015)
Cobalamin C deficiency-associated thrombotic microangiopathy: uncommon or unrecognised?
James N. George
LANCET (2015)
Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency
Steven Grange et al.
LANCET (2015)
Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule
Philippe Gatault et al.
MABS (2015)
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
Richard J. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Insights From the Use in Clinical Practice of Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome Affecting the Native Kidneys: An Analysis of 19 Cases
Fadi Fakhouri et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy
Marina Noris et al.
BLOOD (2014)
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome
M. Cugno et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Pregnancy-Associated Atypical Hemolytic Uremic Syndrome (aHUS), Treated with Eculizumab
Eudokia M. Mandala et al.
BLOOD (2014)
Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic Syndrome
M. Le Quintrec et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults
Veronique Fremeaux-Bacchi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
C. M. Legendre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Determining the Population Frequency of the CFHR3/CFHR1 Deletion at 1q32
Lucy V. Holmes et al.
PLOS ONE (2013)
Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype
Marina Noris et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Clinical Features of Anti-Factor H Autoantibody-Associated Hemolytic Uremic Syndrome
Marie-Agnes Dragon-Durey et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Improving Survival of Malignant Hypertension Patients Over 40 Years
Deirdre A. Lane et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation
M. Le Quintrec et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Ethnic disparities in the incidence, presentation and complications of malignant hypertension
Bert-Jan H. van den Born et al.
JOURNAL OF HYPERTENSION (2006)
Share Paper
